Ignite Creation Date:
2024-05-06 @ 11:52 AM
Last Modification Date:
2024-10-26 @ 12:51 PM
Study NCT ID:
NCT03622333
Status:
UNKNOWN
Last Update Posted:
2018-08-20
First Post:
2018-02-22
Brief Title:
Clinic Pathologic and Genetic Characterization of Patients With Familial Carcinoid Tumors Study From the GTE Groupe détude Des Tumeurs Endocrines
Sponsor:
CHU de Reims
Organization:
CHU de Reims
Study Overview
Official Title:
Clinic Pathologic and Genetic Characterization of Patients With Familial Carcinoid Tumors Study From the GTE Groupe détude Des Tumeurs Endocrines
Status:
UNKNOWN
Status Verified Date:
2018-02
Last Known Status:
RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Small intestine carcinoid tumors are rare Small intestine Familial Carcinoid Tumors FCT are defined by the occurrence of at least 2 cases of this tumor type in first- or second-degree relatives The estimated prevalence of FCT is 26-37 in patients with small intestine carcinoid tumors Because of its rarity epidemiologic clinic and pathologic features of FCT have been scarcely described Molecular abnormalities associated with FCT have been poorly explored Constitutional genetic factors predisposing to FCT have not been discovered to date Only one abnormality mutation of the IPMK gene has been reported in one FCT family only but not found in other series
The main objective of this study is to identify the constitutional factors predisposing to small-intestine FCT and other midgut localizations ascending colon and appendix The secondary objectives are to describe the clinic and pathologic features associated with FCT
The main objective of this study is to identify the constitutional factors predisposing to small-intestine FCT and other midgut localizations ascending colon and appendix The secondary objectives are to describe the clinic and pathologic features associated with FCT
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None